A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer

Clinical trial NCT06016270 · TERMINATED

Trial details

NCT number: NCT06016270
Sponsor: STCube, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer

Start date: 2024-02-13
Primary completion: 2025-01-23
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.